Rand Paul’s Congressional Review Resolution Would Overrule LDT Rule

By Maaisha Osman / May 21, 2024 at 4:40 PM
A resolution has been introduced in the Senate to override FDA’s final rule on the regulation of laboratory-developed tests (LDTs), a move the agency hoped to avoid by speeding through the regulatory process in light of many lawmakers’ disapproval of the policy change. Sen. Rand Paul (R-KY) introduced the resolution under the Congressional Review Act (CRA) Friday (May 17). FDA finalized the rule April 29, after moving quickly to avoid the “midnight rule” period at the end of presidential terms...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.